Key Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3K Buy
71
+6
+9% +$829 ﹤0.01% 375
2026
Q2
$8.35K Buy
65
+16
+33% +$1.87K ﹤0.01% 362
2026
Q1
$5.89K Sell
49
-50
-51% -$5.77K ﹤0.01% 364
2025
Q4
$10.4K Buy
+99
New +$9.29K 0.01% 272

Other funds holding MRK

Key Capital Management's MRK Position: Q3 2026 in Review

Key Capital Management increased its Merck (MRK) stake by 9.2% in Q3 2026, buying an estimated $829 and bringing the position to 71 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #375.

Key Capital Management first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. The position peaked at $10.4K in Q4 2025. 2,771 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Key Capital Management held 71 shares of Merck worth $10.3K as of Q3 2026.
  • Key Capital Management bought 6 Merck shares in Q3 2026, an estimated $829.
  • Merck made up ﹤0.01% of Key Capital Management's portfolio in Q3 2026, its #375 holding.
  • Key Capital Management first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • Key Capital Management's Merck position peaked at $10.4K in Q4 2025.
  • 2,771 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.